首页> 美国卫生研究院文献>Frontiers in Endocrinology >Isolated Pheochromocytoma in a 73-Year-Old Man With No Clinical Manifestations of Type 1 Neurofibromatosis Carrying an Unsuspected Deletion of the Entire NF1 Gene
【2h】

Isolated Pheochromocytoma in a 73-Year-Old Man With No Clinical Manifestations of Type 1 Neurofibromatosis Carrying an Unsuspected Deletion of the Entire NF1 Gene

机译:73岁的老人没有临床表现出携带整个NF1基因的意外删除1型神经纤维瘤病的孤立的嗜铬细胞瘤。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Pheochromocytomas (PHEOs) are a rare cause of endocrine hypertension that requires genetic counseling since at least 30% of PHEOs are associated with a germline mutation in a susceptibility gene. Neurofibromatosis type 1, NF1 is amongst the 16 known causing genes for pheochromocytomas/paragangliomas. We report a case of a 73-year-old man with PHEO in whom genetic testing revealed a large pathogenic heterozygous deletion of 1.14 Mb encompassing the entire coding sequence of the NF1 gene while the patient showed no signs of clinical NF1.This case illustrates that the diagnosis of NF1 should not be excluded in patients with PHEO in the absence of clinical diagnosis of the disease and support that older patients with PHEO should also be offered genetic counseling.
机译:嗜铬细胞瘤(PHEO)是内分泌高血压的罕见原因,需要遗传咨询,因为至少30%的PHEO与易感基因的种系突变有关。 1型神经纤维瘤病NF1是16种已知的嗜铬细胞瘤/神经节瘤的致病基因之一。我们报道了一例73岁的PHEO患者,其基因检测显示1.14 Mb的大病原体杂合性缺失,涵盖了NF1基因的整个编码序列,而该患者没有临床NF1的迹象。在缺乏临床诊断的PHEO患者中,不应排除NF1的诊断,并支持对年龄较大的PHEO患者也应提供遗传咨询。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号